<SEC-DOCUMENT>0001851416-26-000026.txt : 20260811
<SEC-HEADER>0001851416-26-000026.hdr.sgml : 20260811
<ACCEPTANCE-DATETIME>20260811132821
ACCESSION NUMBER:		0001851416-26-000026
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20260811
DATE AS OF CHANGE:		20260811

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Vivos Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001716166
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				813224056
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-92230
		FILM NUMBER:		261262202

	BUSINESS ADDRESS:	
		STREET 1:		7921 SOUTHPARK PLAZA,
		STREET 2:		SUITE 210
		CITY:			LITTLETON
		STATE:			CO
		ZIP:			80120
		BUSINESS PHONE:		(866)908-4867

	MAIL ADDRESS:	
		STREET 1:		7921 SOUTHPARK PLAZA,
		STREET 2:		SUITE 210
		CITY:			LITTLETON
		STATE:			CO
		ZIP:			80120

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Vivos BioTechnologies, Inc.
		DATE OF NAME CHANGE:	20170901

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Streeterville Capital LLC
		CENTRAL INDEX KEY:			0001851416
		ORGANIZATION NAME:           	
		EIN:				852954598
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G

	BUSINESS ADDRESS:	
		STREET 1:		303 E WACKER DRIVE
		STREET 2:		SUITE 1040
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60601
		BUSINESS PHONE:		312-297-7000

	MAIL ADDRESS:	
		STREET 1:		303 E WACKER DRIVE
		STREET 2:		SUITE 1040
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60601

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Streetervile Capital LLC
		DATE OF NAME CHANGE:	20210315
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <schemaVersion>X0202</schemaVersion>
<headerData>
    <submissionType>SCHEDULE 13G</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001851416</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <securitiesClassTitle>Common stock, par value $0.0001 per share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>08/11/2026</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001716166</issuerCik>
        <issuerName>Vivos Therapeutics, Inc.</issuerName>
        <issuerCusips>
          <issuerCusipNumber>92859E207</issuerCusipNumber>
        </issuerCusips>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>7921 SOUTHPARK PLAZA,</com:street1>
          <com:street2>SUITE 210</com:street2>
          <com:city>LITTLETON</com:city>
          <com:stateOrCountry>CO</com:stateOrCountry>
          <com:zipCode>80120</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(c)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>Streeterville Capital LLC</reportingPersonName>
      <citizenshipOrOrganization>UT</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>1812031.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>1812031.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>1812031.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <classPercent>9.3</classPercent>
      <typeOfReportingPerson>OO</typeOfReportingPerson>
      <comments>Based on 19,570,972 shares outstanding as of August 10, 2026.</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>Streeterville Management, LLC</reportingPersonName>
      <citizenshipOrOrganization>UT</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>1812031.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>1812031.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>1812031.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <classPercent>9.3</classPercent>
      <typeOfReportingPerson>OO</typeOfReportingPerson>
      <comments>Based on 19,570,972 shares outstanding as of August 10, 2026.</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>

      <reportingPersonName>John M Fife</reportingPersonName>
      <citizenshipOrOrganization>X1</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>1812031.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>1812031.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>1812031.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <classPercent>9.3</classPercent>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
      <comments>Based on 19,570,972 shares outstanding as of August 10, 2026.</comments>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>Vivos Therapeutics, Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>7921 SOUTHPARK PLAZA,, SUITE 210, LITTLETON, COLORADO, 80120</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>This report is filed by Streeterville Capital LLC, Streeterville Management LLC, and John M. Fife with respect to the shares of common stock of the Issuer that are directly beneficially owned by Streeterville Capital LLC and indirectly beneficially owned by the other reporting and filing persons.</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>300 East Randolph Street, Suite 40.150
Chicago, IL 60601</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Streeterville Capital LLC is a Utah limited liability company.
Streeterville Management LLC is a Utah limited liability company.
John M. Fife is a United States citizen.</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>1,812,031</amountBeneficiallyOwned>
        <classPercent>9.25%</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>1,812,031</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>0</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>1,812,031</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>0</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
        <classOwnership5PercentOrLess>N</classOwnership5PercentOrLess>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>N</notApplicableFlag>
        <certifications>By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under &amp;#167; 240.14a-11.

</certifications>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Streeterville Capital LLC</reportingPersonName>
      <signatureDetails>
        <signature>John Fife</signature>
        <title>President</title>
        <date>08/11/2026</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Streeterville Management, LLC</reportingPersonName>
      <signatureDetails>
        <signature>John Fife</signature>
        <title>President</title>
        <date>08/11/2026</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>John M Fife</reportingPersonName>
      <signatureDetails>
        <signature>John Fife</signature>
        <title>John Fife</title>
        <date>08/11/2026</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
